These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 452467)

  • 41. [Efficacy of drug therapy of patients with coronary arteriosclerosis].
    Ignat'ev MV
    Sov Med; 1969 Dec; 32(12):126-7. PubMed ID: 5376010
    [No Abstract]   [Full Text] [Related]  

  • 42. [Evaluation of physical work capacity of patients with chronic ischemic heart disease during treatment with inderal].
    Zadiunchenko VS; Pomerantsev VP; Mikheev AI; Vertkin AL
    Sov Med; 1975 Apr; (4):19-23. PubMed ID: 1188452
    [No Abstract]   [Full Text] [Related]  

  • 43. [Use of curantyl in combination with potassium-containing preparations in chronic ischemic heart disease].
    Vasilevskiĭ VV; Neĭko EM; Debenko MV
    Klin Med (Mosk); 1976 Feb; 54(2):40-2. PubMed ID: 1271716
    [No Abstract]   [Full Text] [Related]  

  • 44. [Chorionic gonadotropin in the treatment of chronic circulatory failure in ischemic heart disease patients].
    Bondarenko IP
    Vrach Delo; 1984 Jul; (7):75-8. PubMed ID: 6475028
    [No Abstract]   [Full Text] [Related]  

  • 45. [Microcirculation in chronic ischemic heart disease and the effects of nitroglycerin on microcirculation].
    Agapova EN; Eliseeva LN
    Ter Arkh; 1980; 52(11):100-4. PubMed ID: 6781086
    [No Abstract]   [Full Text] [Related]  

  • 46. [Use of anaerobic glycolysis activators in chronic ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1981 Mar; (3):81-3. PubMed ID: 7293150
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of complamine on various indicators of hemostasis and microcirculation in chronic ischemic heart disease].
    Bol'shakova RM; Dukhina MA; Furkalo NK; Solovtsova KM; Progonnaia VV
    Vrach Delo; 1978 Jan; (1):36-40. PubMed ID: 625941
    [No Abstract]   [Full Text] [Related]  

  • 48. [Calcium antagonists and adenosine derivatives in the treatment of patients with chronic ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1988 Oct; (10):16-9. PubMed ID: 3218185
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effect of riboxin on hemodynamics and microcirculation in patients with chronic ischemic heart disease].
    Bondarenko IP
    Vrach Delo; 1983 Jan; (1):15-8. PubMed ID: 6868490
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of chronic schizophrenic psychoses with a thioridazine derivative].
    Glatzel J
    Med Welt; 1972 Jan; 23(2):62-4. PubMed ID: 5059991
    [No Abstract]   [Full Text] [Related]  

  • 51. [Tolerance of physical exertion among patients with chronic ischemic heart disease during treatment with butadione].
    Ermalinskiĭ AF; Balakin AK; Miakin'kova MI
    Vrach Delo; 1986 May; (5):53-6. PubMed ID: 3727510
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of nonachlazine on the adenylate cyclase system of the rabbit heart].
    Brusova EG; Baldenkov GN
    Biull Eksp Biol Med; 1987 Nov; 104(11):594-6. PubMed ID: 3676497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of nonachlazine on the size of an experimental myocardial infarct].
    Gatsura SV; Cherpachenko NM; Turilova AI; Afonskaia NI; Pozonov IuB
    Biull Eksp Biol Med; 1984 May; 97(5):574-6. PubMed ID: 6722335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of anaprilin on the contractile and pump functions of the left ventricle in elderly patients with chronic ischemic heart disease].
    Ivanov IA
    Vrach Delo; 1984 Feb; (2):40-3. PubMed ID: 6719868
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment with sidnonimine derivatives of chronic ischemic heart disease patients].
    Kuz'ko NV
    Vrach Delo; 1984 Jul; (7):79-81. PubMed ID: 6548063
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effects of fructose-1,6-diphosphate in patients with chronic ischemic heart disease. Echocardiographic study].
    Pasotti C; Nicrosini S; Fiori G
    Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):315-20. PubMed ID: 2640054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Characteristics of the course of peptic ulcer associated with chronic ischemic heart disease].
    Kushnir LV
    Vrach Delo; 1988 Mar; (3):29-31. PubMed ID: 3394291
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of nitroglycerin on pulmonary gas exchange and ventilation-perfusion ratios in chronic ischemic heart disease].
    Kobuliia BG; Kurashvili RB; Kavtaradze MN
    Klin Med (Mosk); 1984 Mar; 62(3):76-81. PubMed ID: 6425559
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of papaverine and cholinolytics on the function of the hepatobiliary system in patients with cholecystitis associated with chronic ischemic heart disease].
    Kushnir VE; Novopashennaia VV; Sidorova LL; Kuklia IuI
    Vrach Delo; 1987 Dec; (12):19-22. PubMed ID: 3445559
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of nonachlazine on the temperature sensitivity of the lysosomal membranes of the heart muscle in rats in vitro].
    Sysoliatina NA
    Farmakol Toksikol; 1985; 48(3):41-5. PubMed ID: 4029378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.